Vericel (VCEL) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

VCEL Stock Forecast

Vericel stock forecast is as follows: an average price target of $57.33 (represents a 3.89% upside from VCEL’s last price of $55.19) and a rating consensus of 'Buy', based on 5 wall street analysts offering a 1-year stock forecast.

VCEL Price Target

The average price target for Vericel (VCEL) is $57.33 based on 1-year price targets from 5 Wall Street analysts in the past 3 months, with a price target range of $60.00 to $55.00. This represents a potential 3.89% upside from VCEL's last price of $55.19.

VCEL Analyst Ratings

Buy

According to 5 Wall Street analysts, Vericel's rating consensus is 'Buy'. The analyst rating breakdown for VCEL stock is 0 'Strong Buy' (0.00%), 5 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Vericel Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Aug 26, 2024	Ryan Zimmerman	BTIG	$55.00	$50.05	9.89%	-0.34%
Aug 02, 2024	Swayampakula Ramakanth	H.C. Wainwright	$60.00	$47.52	26.26%	8.73%
Jul 16, 2024	Richard Newitter	Truist Financial	$57.00	$52.10	9.40%	3.29%
Jul 05, 2024	Ryan Zimmerman	BTIG	$56.00	$46.68	19.97%	1.48%
Jan 25, 2024	Samuel Brodovsky	Truist Financial	$51.00	$42.60	19.72%	-7.58%
Jan 03, 2023		H.C. Wainwright	$37.00	$25.13	47.23%	-32.95%
Dec 20, 2022		Truist Financial	$25.00	$23.20	7.76%	-54.70%
Jul 18, 2022		BTIG	$34.00	$28.20	20.59%	-38.39%

The latest Vericel stock forecast, released on Aug 26, 2024 by Ryan Zimmerman from BTIG, set a price target of $55.00, which represents a 9.89% increase from the stock price at the time of the forecast ($50.05), and a -0.34% decrease from VCEL last price ($55.19).

Vericel Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	5
Avg Price Target	-	-	$55.80
Last Closing Price	$55.19	$55.19	$55.19
Upside/Downside	-100.00%	-100.00%	1.11%

In the current month, the average price target of Vericel stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Vericel's last price of $55.19. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Aug 26, 2024	BTIG	Buy	Buy	Hold
Aug 16, 2024	Cowen & Co.	Buy	Buy	Hold
Aug 02, 2024	H.C. Wainwright	Buy	Buy	Hold
Jul 05, 2024	BTIG	Buy	Buy	Hold
Jun 25, 2024	Cowen & Co.	Buy	Buy	Hold
Jun 20, 2024	Cowen & Co.	Outperform	Buy	Initialise
May 09, 2024	Truist Financial	Buy	Buy	Hold
May 09, 2024	H.C. Wainwright	Buy	Buy	Hold
Apr 15, 2024	BTIG	Buy	Buy	Hold
Mar 26, 2024	Truist Financial	Buy	Buy	Hold
Mar 26, 2024	H.C. Wainwright	Underperform	Underperform	Hold
Aug 08, 2023	Cowen & Co.		Outperform	Initialise
Jul 18, 2022	BTIG	Buy	Buy	Hold
Feb 25, 2022	SVB Leerink	Outperform	Outperform	Hold

Vericel's last stock rating was published by BTIG on Aug 26, 2024. The company gave VCEL a "Buy" rating, the same as its previous rate.

Vericel Financial Forecast

Vericel Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	$65.00M	-	$45.92M	$41.02M	$52.69M	$38.55M	$37.05M	$36.07M	$47.59M	$34.51M	$39.52M	$34.57M	$45.23M	$32.26M	$20.01M	$26.68M	$39.39M	$30.50M
Avg Forecast	$115.20M	$85.48M	$80.16M	$75.38M	$96.48M	$70.55M	$66.40M	$62.21M	$77.89M	$55.21M	$52.59M	$49.07M	$63.95M	$45.14M	$42.14M	$37.88M	$52.88M	$39.91M	$38.35M	$34.30M	$48.99M	$37.48M	$36.78M	$32.04M	$45.00M	$31.05M	$18.87M	$25.54M	$38.99M	$26.84M
High Forecast	$120.27M	$89.24M	$83.69M	$78.70M	$100.73M	$73.66M	$69.33M	$65.69M	$79.63M	$55.25M	$52.59M	$49.07M	$66.77M	$45.14M	$43.99M	$39.54M	$55.21M	$39.91M	$38.35M	$34.30M	$48.99M	$37.48M	$36.78M	$32.04M	$45.00M	$31.05M	$18.87M	$25.54M	$38.99M	$26.84M
Low Forecast	$110.48M	$81.98M	$76.87M	$72.29M	$92.53M	$67.66M	$63.68M	$58.73M	$76.94M	$55.17M	$52.59M	$49.07M	$63.94M	$45.14M	$40.41M	$36.32M	$50.71M	$39.91M	$38.35M	$34.30M	$48.99M	$37.48M	$36.78M	$32.04M	$45.00M	$31.05M	$18.87M	$25.54M	$38.99M	$26.84M
# Analysts	2	2	2	2	1	1	1	4	5	4	2	2	4	2	2	2	1	1	1	1	2	2	2	2	13	8	8	9	12	7
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.02%	-	1.09%	1.08%	1.00%	0.97%	0.97%	1.05%	0.97%	0.92%	1.07%	1.08%	1.01%	1.04%	1.06%	1.04%	1.01%	1.14%

Vericel's average Quarter revenue forecast for Mar 24 based on 2 analysts is $49.07M, with a low forecast of $49.07M, and a high forecast of $49.07M. VCEL's average Quarter revenue forecast represents a -24.51% decrease compared to the company's last Quarter revenue of $65.00M (Dec 23).

Vericel EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	2	2	2	2	1	1	1	4	5	4	2	2	4	2	2	2	1	1	1	1	2	2	2	2	13	8	8	9	12	7
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	$12.73M	-	$-5.96M	$-7.35M	$6.84M	$-5.44M	$-7.89M	$-6.20M	$4.99M	$-4.25M	$-3.02M	$-2.33M	$12.40M	$5.90M	$-6.91M	$-3.38M	$10.07M	$3.95M
Avg Forecast	$-1.15M	$-851.52K	$-798.52K	$-750.94K	$-961.12K	$-702.84K	$-661.50K	$-619.76K	$-775.94K	$-549.97K	$-523.86K	$-7.44M	$-637.05K	$-449.70K	$-419.74K	$-5.88M	$7.45M	$-1.68M	$-1.61M	$-4.65M	$-2.06M	$-1.58M	$-1.55M	$-2.15M	$-1.89M	$-1.31M	$-793.55K	$-2.53M	$-1.64M	$-1.13M
High Forecast	$-1.10M	$-816.64K	$-765.81K	$-720.18K	$-921.74K	$-674.04K	$-634.40K	$-585.03K	$-766.45K	$-549.58K	$-523.85K	$-5.95M	$-636.95K	$-449.70K	$-402.55K	$-4.71M	$8.94M	$-1.68M	$-1.61M	$-3.72M	$-2.06M	$-1.58M	$-1.55M	$-1.72M	$-1.89M	$-1.31M	$-793.55K	$-2.03M	$-1.64M	$-1.13M
Low Forecast	$-1.20M	$-889.04K	$-833.71K	$-784.03K	$-1.00M	$-733.80K	$-690.64K	$-654.39K	$-793.23K	$-550.36K	$-523.86K	$-8.93M	$-665.12K	$-449.70K	$-438.24K	$-7.06M	$5.96M	$-1.68M	$-1.61M	$-5.58M	$-2.06M	$-1.58M	$-1.55M	$-2.58M	$-1.89M	$-1.31M	$-793.55K	$-3.04M	$-1.64M	$-1.13M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-19.98%	-	14.20%	1.25%	0.92%	3.24%	4.89%	1.33%	-2.42%	2.70%	1.95%	1.08%	-6.55%	-4.52%	8.71%	1.33%	-6.14%	-3.50%

2 analysts predict VCEL's average Quarter EBITDA for Mar 24 to be $-7.44M, with a high of $-5.95M and a low of $-8.93M. This is -158.45% lower than Vericel's previous annual EBITDA (Dec 23) of $12.73M.

Vericel Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	2	2	2	2	1	1	1	4	5	4	2	2	4	2	2	2	1	1	1	1	2	2	2	2	13	8	8	9	12	7
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	$12.99M	-	$-5.02M	$-6.34M	$5.92M	$-6.58M	$-8.84M	$-6.91M	$4.53M	$-4.90M	$-3.79M	$-3.29M	$12.22M	$3.62M	$-8.18M	$-4.71M	$9.50M	$3.47M
Avg Forecast	$27.00M	$5.06M	$2.98M	$2.85M	$18.91M	$1.83M	$402.50K	$-589.71K	$15.01M	$-2.37M	$-4.56M	$-8.51M	$8.52M	$-5.95M	$-7.45M	$-6.73M	$6.77M	$-4.95M	$-5.95M	$-5.32M	$6.96M	$-1.38M	$-4.08M	$-3.03M	$9.87M	$-1.18M	$-10.06M	$-3.53M	$9.58M	$-811.45K
High Forecast	$28.55M	$5.35M	$3.16M	$3.02M	$19.99M	$1.94M	$425.55K	$884.56K	$17.36M	$-2.24M	$-4.32M	$-6.81M	$9.47M	$-5.63M	$-7.06M	$-5.38M	$8.12M	$-4.95M	$-5.95M	$-4.25M	$6.96M	$-1.38M	$-4.08M	$-2.43M	$9.87M	$-1.18M	$-10.06M	$-2.82M	$9.58M	$-811.45K
Low Forecast	$25.56M	$4.79M	$2.83M	$2.70M	$17.90M	$1.74M	$381.06K	$-1.77M	$12.20M	$-2.50M	$-4.82M	$-10.21M	$7.58M	$-6.29M	$-7.88M	$-8.07M	$5.41M	$-4.95M	$-5.95M	$-6.38M	$6.96M	$-1.38M	$-4.08M	$-3.64M	$9.87M	$-1.18M	$-10.06M	$-4.23M	$9.58M	$-811.45K
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.52%	-	0.67%	0.94%	0.87%	1.33%	1.49%	1.30%	0.65%	3.55%	0.93%	1.08%	1.24%	-3.06%	0.81%	1.33%	0.99%	-4.28%

Vericel's average Quarter net income forecast for Mar 24 is $-8.51M, with a range of $-10.21M to $-6.81M. VCEL's average Quarter net income forecast represents a -165.50% decrease compared to the company's last Quarter net income of $12.99M (Dec 23).

Vericel SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	2	2	2	2	1	1	1	4	5	4	2	2	4	2	2	2	1	1	1	1	2	2	2	2	13	8	8	9	12	7
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	$30.88M	-	$30.65M	$29.48M	$26.92M	$26.98M	$27.14M	$25.86M	$25.97M	$22.77M	$26.19M	$22.66M	$18.24M	$16.04M	$16.49M	$18.07M	$16.38M	$14.98M
Avg Forecast	$68.22M	$50.62M	$47.47M	$44.64M	$57.13M	$41.78M	$39.32M	$36.84M	$46.13M	$32.69M	$31.14M	$31.04M	$37.87M	$26.73M	$24.95M	$24.54M	$38.77M	$23.63M	$22.71M	$19.40M	$29.01M	$22.19M	$21.78M	$20.91M	$26.65M	$18.39M	$11.18M	$13.55M	$23.09M	$15.89M
High Forecast	$71.23M	$52.85M	$49.56M	$46.61M	$59.65M	$43.62M	$41.06M	$38.90M	$47.15M	$32.72M	$31.14M	$37.25M	$39.54M	$26.73M	$26.05M	$29.45M	$46.52M	$23.63M	$22.71M	$23.28M	$29.01M	$22.19M	$21.78M	$25.09M	$26.65M	$18.39M	$11.18M	$16.26M	$23.09M	$15.89M
Low Forecast	$65.43M	$48.55M	$45.52M	$42.81M	$54.79M	$40.07M	$37.71M	$34.78M	$45.56M	$32.67M	$31.14M	$24.83M	$37.86M	$26.73M	$23.93M	$19.63M	$31.01M	$23.63M	$22.71M	$15.52M	$29.01M	$22.19M	$21.78M	$16.72M	$26.65M	$18.39M	$11.18M	$10.84M	$23.09M	$15.89M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.82%	-	1.23%	1.20%	0.69%	1.14%	1.20%	1.33%	0.90%	1.03%	1.20%	1.08%	0.68%	0.87%	1.47%	1.33%	0.71%	0.94%

Vericel's average Quarter SG&A projection for Mar 24 is $31.04M, based on 2 Wall Street analysts, with a range of $24.83M to $37.25M. The forecast indicates a 0.54% rise compared to VCEL last annual SG&A of $30.88M (Dec 23).

Vericel EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	2	2	2	2	1	1	1	4	5	4	2	2	4	2	2	2	1	1	1	1	2	2	2	2	13	8	8	9	12	7
EPS	-	-	-	-	-	-	-	-	-	-	-	-	$0.26	-	$-0.11	$-0.13	$0.13	$-0.14	$-0.19	$-0.15	$0.10	$-0.11	$-0.08	$-0.07	$0.27	$0.08	$-0.18	$-0.10	$0.21	$0.08
Avg Forecast	$0.55	$0.10	$0.06	$0.06	$0.39	$0.04	$0.01	$-0.01	$0.31	$-0.05	$-0.09	$-0.11	$0.17	$-0.12	$-0.15	$-0.15	$0.04	$-0.10	$-0.12	$-0.12	$0.14	$-0.03	$-0.08	$-0.04	$0.20	$-0.02	$-0.21	$-0.08	$0.20	$-0.02
High Forecast	$0.58	$0.11	$0.06	$0.06	$0.41	$0.04	$0.01	$0.02	$0.35	$-0.05	$-0.09	$-0.10	$0.19	$-0.11	$-0.14	$-0.15	$0.04	$-0.10	$-0.12	$-0.12	$0.14	$-0.03	$-0.08	$-0.04	$0.20	$-0.02	$-0.21	$-0.08	$0.20	$-0.02
Low Forecast	$0.52	$0.10	$0.06	$0.06	$0.36	$0.04	$0.01	$-0.04	$0.25	$-0.05	$-0.10	$-0.12	$0.15	$-0.13	$-0.16	$-0.16	$0.03	$-0.10	$-0.12	$-0.12	$0.14	$-0.03	$-0.08	$-0.04	$0.20	$-0.02	$-0.21	$-0.08	$0.20	$-0.02
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.50%	-	0.72%	0.85%	3.61%	1.38%	1.55%	1.28%	0.68%	3.88%	0.97%	1.73%	1.33%	-3.29%	0.87%	1.18%	1.07%	-4.80%

According to 2 Wall Street analysts, Vericel's projected average Quarter EPS for Mar 24 is $-0.11, with a low estimate of $-0.12 and a high estimate of $-0.10. This represents a -142.37% decrease compared to VCEL previous annual EPS of $0.26 (Dec 23).

Vericel Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
KROS	Keros Therapeutics	$18.00	$102.00	466.67%	Buy
XFOR	X4 Pharmaceuticals	$0.74	$3.67	395.95%	Buy
IPSC	Century Therapeutics	$1.17	$5.00	327.35%	Buy
RLAY	Relay Therapeutics	$4.50	$18.00	300.00%	Buy
RGNX	REGENXBIO	$8.47	$29.75	251.24%	Buy
CLGN	CollPlant Bio	$3.64	$12.50	243.41%	Buy
TERN	Terns Pharmaceuticals	$6.80	$18.67	174.56%	Buy
PLRX	Pliant Therapeutics	$14.37	$35.50	147.04%	Buy
MREO	Mereo BioPharma Group	$3.40	$8.00	135.29%	Buy
SNDX	Syndax Pharmaceuticals	$13.63	$31.67	132.36%	Buy
STOK	Stoke Therapeutics	$12.10	$26.50	119.01%	Buy
IDYA	IDEAYA Biosciences	$26.33	$53.33	102.54%	Buy
DAWN	Day One Biopharmaceuticals	$12.64	$24.00	89.87%	Buy
CYTK	Cytokinetics	$47.78	$90.00	88.36%	Buy
DYN	Dyne Therapeutics	$26.16	$49.00	87.31%	Buy
MRUS	Merus	$44.90	$81.25	80.96%	Buy
RVMD	Revolution Medicines	$45.16	$65.67	45.42%	Buy
BPMC	Blueprint Medicines	$96.48	$122.60	27.07%	Buy
CRNX	Crinetics Pharmaceuticals	$55.37	$69.00	24.62%	Buy
XNCR	Xencor	$25.04	$30.00	19.81%	Buy
VCEL	Vericel	$56.69	$57.33	1.13%	Buy

VCEL Forecast FAQ

Is Vericel a good buy?

Yes, according to 5 Wall Street analysts, Vericel (VCEL) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 5 'Buy' recommendations, accounting for 100.00% of VCEL's total ratings.

What is VCEL's price target?

Vericel (VCEL) average price target is $57.33 with a range of $55 to $60, implying a 3.89% from its last price of $55.19. The data is based on 5 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Vericel stock go up soon?

According to Wall Street analysts' prediction for VCEL stock, the company can go up by 3.89% (from the last price of $55.19 to the average price target of $57.33), up by 8.73% based on the highest stock price target, and down by -0.34% based on the lowest stock price target.

Can Vericel stock reach $80?

VCEL's average twelve months analyst stock price target of $57.33 does not support the claim that Vericel can reach $80 in the near future.

What are Vericel's analysts' financial forecasts?

Vericel's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $295.65M (high $309.41M, low $282.6M), average EBITDA is $-2.945M (high $-2.815M, low $-3.082M), average net income is $20.56M (high $23.24M, low $18.25M), average SG&A $175.08M (high $183.23M, low $167.35M), and average EPS is $0.419 (high $0.474, low $0.372). VCEL's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $356.22M (high $371.91M, low $341.62M), average EBITDA is $-3.549M (high $-3.403M, low $-3.705M), average net income is $37.9M (high $40.07M, low $35.88M), average SG&A $210.95M (high $220.24M, low $202.31M), and average EPS is $0.772 (high $0.816, low $0.731).

Did the VCEL's actual financial results beat the analysts' financial forecasts?

Based on Vericel's last annual report (Dec 2023), the company's revenue was $197.52M, beating the average analysts forecast of $189.1M by 4.45%. Apple's EBITDA was $-6.464M, missing the average prediction of $-7.389M by -12.52%. The company's net income was $-3.182M, missing the average estimation of $-11.606M by -72.58%. Apple's SG&A was $121M, beating the average forecast of $114.09M by 6.05%. Lastly, the company's EPS was $-0.0669, missing the average prediction of $-0.253 by -73.53%. In terms of the last quarterly report (Dec 2023), Vericel's revenue was $65M, beating the average analysts' forecast of $63.95M by 1.64%. The company's EBITDA was $12.73M, missing the average prediction of $-637K by -2098.43%. Vericel's net income was $12.99M, beating the average estimation of $8.52M by 52.43%. The company's SG&A was $30.88M, missing the average forecast of $37.87M by -18.47%. Lastly, the company's EPS was $0.26, beating the average prediction of $0.174 by 49.72%